Catalina Mourgues

Catalina Mourgues

Auto-generated profile, based on publicly available information

Catalina Mourgues

Yale University School of Medicine and the Connecticut Mental Health Center, New Haven, CT, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2010 in Consciousness and Cognition
Verified
Journal Article
Closed access
RRRicardo Rosas
Ricardo Rosas
FCFrancisco Ceric
Francisco Ceric
MTMarcela Tenorio
Marcela Tenorio
CMCatalina Mourgues
Catalina Mourgues
CTCarolina Thibaut
Carolina Thibaut
MAMaria Teresa Aravena
Maria Teresa Aravena

26 November 2025 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
HHHadar Hazan
Hadar Hazan
STSümeyra N. Tayfur
Sümeyra N. Tayfur
SKSneha Karmani
Sneha Karmani
TGTony Gibbs-Dean
Tony Gibbs-Dean
CMCatalina Mourgues
Catalina Mourgues
VSVinod Srihari
Vinod Srihari
Background: Insight into psychosis is a multidimensional construct involving awareness of illness, attribution of symptoms, and perceived need for treatment. Despite extensive research, substantial variability in how insight is conceptualized and measured continues to hinder clinical assessment and cross-study comparisons. Methods: Following Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols guidelines and a registered International Prospective Register of Systematic Reviews protocol (CRD42024558386), we conducted a systematic search across five databases ( n = 2,184). Twenty-nine studies met the inclusion criteria, comprising 15 primary scale development papers and 10 independent validation studies. We included instruments explicitly designed to assess insight in schizophrenia-spectrum, and evaluated them using the COnsensus-based Standards for the selection of health Measurement INstruments Risk of Bias checklist. Psychometric domains assessed included content validity, structural validity, construct validity, criterion validity, internal consistency, reliability, responsiveness, and interpretability. Results: Fifteen distinct insight scales were identified, comprising nine clinician-rated instruments, five self-report tools, and one hybrid format. Most demonstrated adequate content and structural validity, with 11 achieving ‘very good’ reliability ratings. Four scales showed the strongest overall psychometric support. However, responsiveness to clinical change was rarely tested, and cross-cultural validation remained limited. Earlier instruments primarily emphasized clinician-rated illness awareness, whereas more recent tools incorporated cognitive, neurocognitive, and subjective dimensions. Discrepancies between self-report and clinician ratings were common and often clinically meaningful. These findings underscore the need for multidimensional, psychometrically robust, and context-sensitive tools to advance both clinical assessment and research on insight in psychotic disorders.

5 August 2022 in Mind, Brain, and Education
Verified
Journal Article
Closed access
MTMei Tan
Mei Tan
IMIlia Markov
Ilia Markov
CMCatalina Mourgues
Catalina Mourgues
EGElena L. Grigorenko
Elena L. Grigorenko

1 October 2026 in Psychiatric Services
Verified
Journal Article
Closed access
ABAlexander Broekhuijse
Alexander Broekhuijse
ASAbhishek Saxena
Abhishek Saxena
BWBarbara Walsh
Barbara Walsh
CMCatalina Mourgues-Codern
Catalina Mourgues-Codern
HMHesham Mukhtar
Hesham Mukhtar
EFEmily A. Farina
Emily A. Farina

8 October 2021 in PsyArXiv
Verified
Preprint
Open access
EKEren Kafadar
Eren Kafadar
VFVictoria Fisher
Victoria Fisher
BQBrittany Quagan
Brittany Quagan
AHAllison Hammer
Allison Hammer
HJHale Jaeger
Hale Jaeger
APAlbert Powers
Albert Powers
Recent advances in computational psychiatry have identified latent cognitive and perceptual states that predispose to psychotic symptoms. Behavioral data fit to Bayesian models have demonstrated an over-reliance on priors during perception in select samples of individuals with hallucinations. However, the clinical utility of this observation depends on whether it reflects static symptom risk or current symptom state. To determine whether task performance and estimated prior weighting related to specific elements of symptom expression, a large, heterogeneous, and deeply-phenotyped sample of hallucinators (N = 249) and non-hallucinators (N=209) performed the Conditioned Hallucination (CH) task. CH rates were sensitive to hallucination state, correlating with hallucination severity measures over the two days leading up to task completion and driven by heightened reliance on past experiences (priors). To further test this relationship, a subset of AH+ participants (N = 40) performed a repeated-measures version of the CH task. Changes in both CH frequency and relative prior precision varied with changes in AH frequency on follow-up. These results support the use of CH rate and prior hyper-precision as state markers of hallucination status, potentially useful in tracking disease development and treatment response.

17 September 2021 in PsyArXiv
Verified
Preprint
Open access
CMCatalina Mourgues
Catalina Mourgues
AHAllison Hammer
Allison Hammer
VFVictoria Fisher
Victoria Fisher
EKEren Kafadar
Eren Kafadar
BQBrittany Quagan
Brittany Quagan
APAlbert Powers
Albert Powers
Auditory verbal hallucinations (AVH) frequently cause significant distress and dysfunction, and may be unresponsive to conventional treatments. Some voice-hearers report an ability to fully control the onset and offset of their AVH, making them significantly less disruptive. Measuring and understanding these abilities may lead to novel interventions to enhance control over AVH.52 voice-hearers participated in the pilot study. 318 participants with frequent AVH participated in the validation study. A pool of 59 items was developed by a diverse team including voice-hearers and clinicians. After the pilot study, 35 items were retained. Factorial structure was assessed with exploratory (EFA, n = 148) and confirmatory (CFA, n = 170) factor analyses. Reliability and convergent validity were assessed using a comprehensive battery of validated phenomenological and clinical scales. CFA supported two factors for a Methods of Control Scale (5 items each, average ω = .87), and one factor for a Degree of Control Scale (8 items, average ω = .95). Correlation with clinical measures supported convergent validity. Degree of control was associated with positive clinical outcomes in voice-hearers both with and without a psychosis-spectrum diagnosis. Degree of control also varied with quality of life independently of symptom severity and AVH content.The Yale COPE Scales are the first measure of voice-hearers’ control over AVH and exhibit sound psychometric properties. Results demonstrate that the capacity to voluntarily control AVH is independently associated with positive clinical outcomes. Reliable measurement of control over AVH will enable future development of interventions meant to bolster that control.